ACHFF

ARCH BIOPARTNERS INC ORD by Arch Biopartners Inc. (ACHFF)

About ARCH BIOPARTNERS INC ORD by Arch Biopartners Inc. (ACHFF)

Arch Biopartners, Inc. is a portfolio-based biotechnology company, which engages in the development of technologies that have the potential to make a significant medical or commercial impact. Its technology platforms include AB569 and Borg: Peptide-Solid Surface Interface. The company was founded by Richard Gabriel Muruve and Daniel Muruve on March 4, 1983 and is headquartered in Toronto, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.74
52 Week Low
$0.89
Market cap
83.3M
Dividend yield
0.00%
Volume
--
Avg. volume
6,348
P/E ratio
-30.98

ARCH BIOPARTNERS INC ORD by Arch Biopartners Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.74
52 Week Low
$0.89
Market cap
83.3M
Dividend yield
0.00%
Volume
--
Avg. volume
6,348
P/E ratio
-30.98